Showing results (1-10 of 174) with videos related to
Sort By:
Pageof 18
Current Opinion in Pharmacology|July 11, 2014
Immunomodulation in cancerJoost P J J Hegmans, Joachim G J V AertsMolecular Therapy Oncolytics|April 26, 2019
Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional TreatmentRobert A Belderbos, Joachim G J V Aerts, Heleen VromanFrontiers in Oncology|June 26, 2020
Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural MesotheliomaRobert A Belderbos, Heleen Vroman, Joachim G J V AertsFrontiers in Immunology|December 19, 2018
Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets?Anne Huber, Floris Dammeijer, Joachim G J V Aerts, et al.Journal of Oncology|March 13, 2010
A patient with four-year survival after nonsmall cell lung carcinoma with a solitary metachronous small bowel metastasisKlaas M Kant, Vincent Noordhoek Hegt, Joachim G J V AertsNederlands Tijdschrift Voor Geneeskunde|July 17, 2025
[Financial toxicity in cancer patients]Jente M Klok, David Van Klaveren, Joachim G J V AertsFrontiers in Oncology|April 1, 2020
Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?Luca Cantini, Raffit Hassan, Daniel H Sterman, et al.Frontiers in Immunology|December 21, 2018
Combination Strategies to Optimize Efficacy of Dendritic Cell-Based ImmunotherapyMandy van Gulijk, Floris Dammeijer, Joachim G J V Aerts, et al.Immunotherapy|May 6, 2017
Immunotherapeutic strategies in non-small-cell lung cancer: the present and the futureChristi M Steendam, Floris Dammeijer, Joachim G J V Aerts, et al.Lung Cancer (Amsterdam, Netherlands)|February 3, 2022
Immunotherapy for mesothelioma: Moving beyond single immune check point inhibitionLuca Cantini, Isaac Laniado, Vivek Murthy, et al.Pageof 18